Advagraf + Prograf + Corticosteroid + Mycophenolate mofetil
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
de Novo Kidney Transplantation
Conditions
de Novo Kidney Transplantation
Trial Timeline
Apr 1, 2012 → Jun 1, 2012
NCT ID
NCT01742624About Advagraf + Prograf + Corticosteroid + Mycophenolate mofetil
Advagraf + Prograf + Corticosteroid + Mycophenolate mofetil is a approved stage product being developed by Astellas Pharma for de Novo Kidney Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT01742624. Target conditions include de Novo Kidney Transplantation.
What happened to similar drugs?
8 of 15 similar drugs in de Novo Kidney Transplantation were approved
Approved (8) Terminated (1) Active (6)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01742624 | Approved | Completed |
Competing Products
19 competing products in de Novo Kidney Transplantation